A large scale proteome analysis of the gefitinib primary resistance ...

Knowledge of these mechanisms may inform combination strategies to attack both oncogenic KRAS and subsequent bypass mechanisms. Key words: KRAS, ...







Abnormalities in the KRAS Gene and Treatment ... - PPM UMLub
The combined use of HDACi overcomes the resistance to MEK inhibitors caused by the downregulation of MAPK pathway negative regulators [261].
From target to KRAS broad range treatment - FLORE
Osimertinib, predicted by our computational platform during the course of this study, acts upstream of KRAS. G12C to inhibit EGFR, specifically ...
Targeting KRAS mutations in pancreatic cancer - Semantic Scholar
Our findings support TEAD inhibition as a therapeutic combination strategy to enhance the response rate and durability of direct KRAS inhibitor therapies.



Autres Cours:

????